# Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

> **NCT01390805** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 462 (actual)

## Conditions studied

- Genital Herpes

## Interventions

- **DRUG:** Valaciclovir Hydrochloride.

## Key facts

- **NCT ID:** NCT01390805
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-04
- **Final completion:** 2011-03
- **Target enrollment:** 462 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01390805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01390805, "Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01390805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*